No Images? Click here

Medical Advisory

MEMO: Td-IPV Discontinued & Seasonal Influenza Vaccine Supply Depleted, Feb. 13, 2019

TO:  Health Care Providers Who Order & Store Publicly Funded Vaccine

FROM: Vaccine Preventable Disease program (VPD program)

REFERENCE:  Td-IPV Discontinued & Seasonal Influenza Vaccine Supply Depleted

DATE:  Feb. 13, 2019                                                                                                  

Td-IPV Discontinued

  • Td-IPV has been discontinued by the manufacturer and is no longer available for order
  • As per the Ministry of Health and Long-Term Care, when Td-IPV is indicated, Td (Td Adsorbed®)  and IPV (Imovax® Polio) are available to administer separately
    • In these instances, you may consider using Tdap-IPV (Adacel®-Polio or Boostrix®-Polio) to provide additional protection against pertussis if required
  • Please review your vaccine needs and order sufficient doses of Td, IPV or Tdap-IPV
  • Td-IPV stock currently in circulation expired on January 31, 2019.  See"Excursions and Returns" for details on how to return expired vaccine.

Seasonal Influenza Vaccine Supply Depleted

  • Due to increased demand, the provincial supply of most seasonal influenza vaccines (FluMist® Quadrivalent, FluLaval® Tetra, Fluzone® Quadrivalent) have been depleted
  • Niagara Region Public Health and Emergency Services does not have influenza vaccine available to fill orders
  • Your office may direct clients wanting the flu vaccine to check with their local pharmacist regarding availability
  • Please consider prioritizing any remaining doses you may have to populations that pharmacies are unable to immunize (e.g. children between 6 months to 4 years of age)

For More Information

For more information, please contact the VPD program at 1-888-505-6074 or 905-688-8248 ext. 7396.

 
Niagara Region Public Health
1815 Sir Isaac Brock Way, Thorold, L2V 4T7
Tel: 905-688-8248 • Toll Free: 1-888-505-6074
You have received this email from Niagara Region Public Health because you subscribed to our mailing list.
  Like 
  Tweet 
  Share 
  Forward 
Preferences  |  Unsubscribe